APVO436 Phase 1b/2 Study in Patients With Newly Diagnosed AML
APVO436 Phase 1b/2 Study in Patients With Newly Diagnosed AML
Recruiting · NCT06634394 · Registry updated 2025-05-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| APVO436 Phase 1b/2 Study in Patients With Newly Diagnosed AML | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Recruiting | Phase 1 | 2025-05-11 | NCT06634394 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Aptevo Therapeutics | 1 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Colorado Blood Cancer Institute | Denver | United States | 178 |
| Gabrail Cancer Center | Canton | United States | 39 |
| MD Anderson Cancer Center | Houston | United States | 589 |
| Oncology Hematology Care | Cincinnati | United States | 4 |
| University of Kansas | Fairway | United States | 8 |
| University of Miami | Miami | United States | 5 |
| University of Texas Southwestern Medical Center | Dallas | United States | 249 |